BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND FANCA, MGC75158, 2175, ENSG00000187741, FA-H, FA, FAA, FANCH, FA1, FACA AND Diagnosis
122 results:

  • 1. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
    Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
    J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Chitosan nanoplatform for the co-delivery of palbociclib and ultra-small magnesium nanoclusters: dual receptor targeting, therapy and imaging.
    Mehata AK; Singh V; Vikas ; Srivastava P; Koch B; Kumar M; Muthu MS
    Nanotheranostics; 2024; 8(2):179-201. PubMed ID: 38444739
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Differential diagnosis of breast mucinous carcinoma with an oval shape from fibroadenoma based on ultrasonographic features.
    Wang H; Hu Y; Tan C; Gu R; Li Y; Jin L; Jiang X; Mei J; Liu Q; Gong C
    BMC Womens Health; 2024 Feb; 24(1):87. PubMed ID: 38310239
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Imaging and Management of Fibroepithelial Lesions of the breast: Radiologic-Pathologic Correlation.
    Zhang M; Arjmandi FK; Porembka JH; Seiler SJ; Goudreau SH; Merchant K; Hwang H; Hayes JC
    Radiographics; 2023 Nov; 43(11):e230051. PubMed ID: 37856317
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Hepatic adenoma in a 7-year-old girl: a case report and literature review.
    Gao Y; Zhou J; Xie YC; Qiu LJ; Duan L; A ZX; Wu HF; Lv MX
    BMC Pediatr; 2023 Aug; 23(1):420. PubMed ID: 37620840
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Differentiation between Phyllodes Tumors and Fibroadenomas through breast Ultrasound: Deep-Learning Model Outperforms Ultrasound Physicians.
    Shi Z; Ma Y; Ma X; Jin A; Zhou J; Li N; Sheng D; Chang C; Chen J; Li J
    Sensors (Basel); 2023 May; 23(11):. PubMed ID: 37299826
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Stromal Ki67 Expression Might be a Useful Marker for Distinguishing Fibroadenoma From Benign Phyllodes Tumor of the breast.
    Yuan M; Saeki H; Horimoto Y; Ishizuka Y; Onagi H; Saito M; Hayashi T; Arakawa A; Yao T
    Int J Surg Pathol; 2024 Apr; 32(2):223-229. PubMed ID: 37157807
    [No Abstract]    [Full Text] [Related]  

  • 8. Automatic Detection of Benign/Malignant Tumor in breast Ultrasound Images using Optimal Features.
    Yang Y; Liu Q; Dai T; Zhang H
    Curr Med Imaging; 2023; 19(13):1570-1579. PubMed ID: 36683320
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Differential diagnosis of DCIS and Fibroadenoma Based on Ultrasound Images: a Difference-Based Self-Supervised Approach.
    Yin J; Qiu JJ; Liu JY; Li YY; Lao QC; Zhong XR; Feng M; Du H; Peng SL; Peng YL
    Interdiscip Sci; 2023 Jun; 15(2):262-272. PubMed ID: 36656448
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. "Growing fibroadenoma": Are there clinical and pathological features predicting a phyllodes tumor on surgical excision?
    Nam G; Donegan L; Gorbounov M; Hacking S; Wiggins D; Ward R; Yakirevich E; Wang Y
    Ann Diagn Pathol; 2023 Feb; 62():152069. PubMed ID: 36527840
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Characterizing breast cancer incidence and trends among Asian American, Native Hawaiian, and non-Hispanic White women in Hawai'i, 1990-2014.
    Ihenacho U; McKinley MA; Vu A; Hernandez BY; Loo LWM; Gomez SL; Wu AH; Cheng I
    Cancer Causes Control; 2023 Mar; 34(3):241-249. PubMed ID: 36504334
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Survey of recurrent diagnostic challenges in breast phyllodes tumours.
    Tan BY; Fox SB; Lakhani SR; Tan PH
    Histopathology; 2023 Jan; 82(1):95-105. PubMed ID: 36468287
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Lack of impact of the ALDH2 rs671 variant on breast cancer development in Japanese BRCA1/2-mutation carriers.
    Mori T; Okamoto Y; Mu A; Ide Y; Yoshimura A; Senda N; Inagaki-Kawata Y; Kawashima M; Kitao H; Tokunaga E; Miyoshi Y; Ohsumi S; Tsugawa K; Ohta T; Katagiri T; Ohtsuru S; Koike K; Ogawa S; Toi M; Iwata H; Nakamura S; Matsuo K; Takata M
    Cancer Med; 2023 Mar; 12(6):6594-6602. PubMed ID: 36345163
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Radiologic-Pathologic Correlation of Fibroepithelial Lesions: A Pictorial Review.
    Zhang M; Compton L; Hwang H; Hayes JC
    J Breast Imaging; 2022 Oct; 4(5):513-519. PubMed ID: 38416944
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Fabrication of FA/HA-functionalized carbon dots for human breast cancer cell targeted imaging.
    Tao J; Zou H; Liao X; Lu X; Cao J; Pan J; Li C; Zheng Y
    Photodiagnosis Photodyn Ther; 2022 Dec; 40():103099. PubMed ID: 36055626
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22).
    Musacchio L; Califano D; Bartoletti M; Arenare L; Lorusso D; Losito NS; Cormio G; Greggi S; Raspagliesi F; Valabrega G; Salutari V; Pisano C; Spina A; Russo D; Del Sesto M; Canzonieri V; FerraĆ¹ F; Zannoni GF; Loizzi V; Ghizzoni V; Casanova C; Tuninetti V; Ducceschi M; Del Vecchio V; Scalone S; Priolo D; Perrone F; Scambia G; Pignata S
    Br J Cancer; 2022 Nov; 127(8):1479-1486. PubMed ID: 35869143
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The value of whole-tumor histogram and texture analysis based on apparent diffusion coefficient (ADC) maps for the discrimination of breast fibroepithelial lesions: corresponds to clinical management decisions.
    Li X; Chai W; Sun K; Fu C; Yan F
    Jpn J Radiol; 2022 Dec; 40(12):1263-1271. PubMed ID: 35793052
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Predictive value of DNA repair gene expression for response to neoadjuvant chemotherapy in breast cancer.
    Kneubil MC; Goulart KOB; Brollo J; Coelho GP; Mandelli J; Orlandin BC; Corso LL; Roesch-Ely M; Henriques JAP
    Braz J Med Biol Res; 2022; 55():e11857. PubMed ID: 35293552
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. miR-140-3p is a potential differential biomarker in benign phyllodes tumors and fibroadenoma of the breast.
    Li Q; Liu Y; Bai J; Zhao S; Wang Y; Shabbir A; Zhang K; Jiang F; Zhu J; Ma R; Wang J
    BMC Womens Health; 2022 Feb; 22(1):31. PubMed ID: 35120526
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Combination of Neutrophil-to-Lymphocyte Ratio and Red Cell Distribution Width With Serum Tumor Markers for the Differential diagnosis of breast cancer and its Association With Pathological Features and Molecular Types.
    Zou H; Liu SH; Yang R; Wu XJ; Cao YP; Huang HF
    Clin Breast Cancer; 2022 Jun; 22(4):e526-e535. PubMed ID: 34963613
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.